Award-Winning Physician and Endocrinologist Claims that Anyone in Fear of Getting Cancer Needs Prevennia®

Containing the Most Powerful Levels of Antioxidants, Prevennia Blocks the Formation of Cancerous Cells

LAS VEGAS--(BUSINESS WIRE)-- Board Certified Endocrinologist Dr. David Westbrock today announced his support of Prevennia, a new nutritional supplement scientifically proven to block DNA damage, which is the first step in cell mutation, that could lead to over 6,000 life altering diseases, including breast and prostate cancer.

According to the American Cancer Society’s annual report, over 1.5 million people were diagnosed with cancer in 2010, over 530,000 people die of cancer each year, and one in two men will develop cancer in their lifetime, with one in three women following suit.

“Cancer is a scary word and should not be taken lightly when it comes to preventative treatments and remedies,” states Dr. David Westbrock, a medical physician board certified by the American Board of Internal Medicine. “I understand firsthand the fears and the trials and tribulations that come with debilitating and life altering disease. When I was first introduced to this new nutritional supplement, Prevennia, I was skeptical. But after reviewing the research conducted by Dr. Eleanor Rogan and Dr. Ercole Cavalieri of the Eppley Institute for Cancer Research and Allied Diseases at the University of Nebraska Medical Center, I was intrigued by their exhaustive research, their level of integrity and the over 250 published articles supporting their research, as well as the derivation of their research. As a physician who has specialized in hormonal disorders, it is exciting to have a product available that can help prevent breast cancer and prostate cancer,” claims Dr. Westbrock.

The doctors began their research over 40 years ago, searching for the origin of the cancer cell. As a result, they discovered that unbalanced levels of estrogen metabolites can cause estrogen-DNA adducts to form and damage, or mutate, cells. Mutated cells can lead to cancerous tumors. Prevennia, although not stating that it prevents cancer, is scientifically proven to balance estrogen metabolism and block estrogen-DNA adducts from forming and mutating cells.

Dr. Westbrock continued by stating, “Prevennia is the best product available today that could help my patients, both men and women, balance their estrogen metabolism. If I have a patient who I feel is a candidate for getting cancer, I will highly recommend they take Prevennia. At last, with all the fear of hormones we call sex steroids in regard to cancer, we have an agent in the fight against cancer. I am one doctor who welcomes a new agent in the fight against cancer. Everyone should be aware of Prevennia and I am doing my part to aid Prevennia in becoming a household name. I was so impressed with Prevennia, I agreed to become a medical spokesperson for the company.”

Dr. David Westbrock has been in private practice for over 30 years in Dayton, Ohio. He received his undergraduate degree from the University of Dayton and his medical degree from The Ohio State University. His recommendation of Prevennia is a crucial step in the success of the company and their ability to impress upon the public the importance of maintaining balanced levels of estrogen in order to avoid life threatening disease such as breast and prostate cancer.

About Prevennia

Over the past three decades, the National Cancer Institute and Department of Defense granted $38 million to the award-winning researchers Dr. Eleanor Rogan and Dr. Ercole Cavalieri, creators of Prevennia. These researchers have been conducting scientific studies proving in laboratory testing that the unique combination of the all-natural antioxidants in Prevennia blocks the triggering mechanisms that cause DNA degradation by keeping estrogen metabolism in balance. This means, in theory, that Prevennia has the ability to block the first step that leads down the pathway to life-altering disease, including breast and prostate cancer. Prevennia is being introduced to the public as a means of keeping the body in balance in order to combat the effects of high levels of estrogen-DNA adducts in both men and women.

Prevennia.com
Where Prevention Begins…

For more information please visit
www.prevennia.com

Facebook: http://www.facebook.com/Prevennia

Twitter: http://twitter.com/#!/prevennia

Blog: http://prevennia.tumblr.com/



CONTACT:

EQ Biosciences, Inc.
Robynn Anton, 513-520-8103
[email protected]

KEYWORDS:   United States  North America  Nevada  Ohio

INDUSTRY KEYWORDS:   Seniors  Women  Health  Alternative Medicine  Biotechnology  Clinical Trials  Fitness & Nutrition  Genetics  Oncology  Other Health  Research  Other Science  Consumer  Family  Science  Men

MEDIA:

Logo
 Logo

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.